Barrow Hanley Mewhinney & Strauss LLC Organon & Co. Transaction History

Barrow Hanley Mewhinney & Strauss LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $2.88 Million - $3.72 Million	-94,500 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $1.31 Million - $1.69 Million	-45,632 Reduced 32.56%	94,500 $2.88 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $2.56 Million - $3.18 Million	89,259 Added 175.45%	140,132 $4.6 Million
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $1.45 Million - $1.93 Million	50,873 New	50,873 $1.54 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.